Grace Therapeutics Inc.

NASDAQ: GRCE
Share price (1/6/25): $4.14
Market cap (1/6/25): $42.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q2

ended 06/30/24 Q1

ended 03/31/24 FY 2024

ended 12/31/23 Q3

ended 09/30/23 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Updated info for already-effective prospectus

Ownership Filter

ADAR1 Capital Management, LLC

Bank of America Corporation

ADAR1 Partners, LP, ADAR1 Capital Management, LLC

ADAR1 Capital Management, LLC

ADAR1 Partners, LP, ADAR1 Capital Management, LLC

News Filter

Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Acasti Announces Corporate Name Change to Grace Therapeutics, Inc

Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC